- Visibility11
- Citations0
- Sentiment50
- Site quality87
- AI readiness29
AI assistants rarely name Halozyme Therapeutics in their answers, mentioning it in 2 out of 60 responses, sometimes alongside Ypsomed. Its overall score is 31 out of 100, ranking 1,166th of 2,047 companies and below the typical company in its sector. The website passes 4 out of 14 technical checks for readiness for AI tools.
We asked 15 unbranded questions about the technology market: none named Halozyme Therapeutics. AI assistants named it in 2 of 60 answers (3.3%). The typical technology company is named in 10.0% of answers. By how often it is named, Halozyme Therapeutics ranks 200 of 273 in its sector.
Named fewer than three times in total. Read this as a sign that AI assistants rarely bring this company up, not as an exact comparison with its rivals.
Every dot is a company in the study. Hover one to see it; click to open its report.
This companySame sectorEvery other companyNever named
Five parts, each scored out of 100.
How often AI assistants name the company
How often AI uses the company's own website as a source
How positively AI describes the company
How well built the website's own pages are
How easily AI tools can read and use the website
Visibility is calculated from the answers on this page. How the score is built.
273 companies in this sector. The line on each bar is the typical company.
An answer that names the company
“What are the most innovative drug delivery technologies currently used to enhance patient experience in the US?”
Below are the most important, patient‑facing drug‑delivery technologies being used or translated into routine care in the U.S. today, with a short note about why each improves the patient experience and citations to representative, recent sources.
1) Improved inhalation systems (DPIs, soft‑mist inhalers, vibrating‑mesh nebulizers)
Why it helps patients: non‑invasive delivery, faster onset for respiratory drugs, better portability and reliability, and new formulation/particle‑engineering advances that allow delivery of proteins and higher-efficiency dosing.
Sources: reviews on dry‑powd …
The AI’s answer as we received it, shortened and not checked for accuracy.
How the mentions in these answers were split between this company and its rivals
Answers naming it, out of answers received
What this website publishes for an AI agent to read, use and buy from, on a scale of six levels.
- 0
- 1
- 2
- 3
- 4
- 5
Level 1: Basic web presence. Two of robots.txt, a sitemap and Link headers are in place.
- Content Signals
Show every check, for your technical teamHide the checks
- study: 92.0%robots.txtPassed
A valid robots.txt with crawl rules at the site root.
- study: 86.8%SitemapPartly met
Serve an XML sitemap and reference it from robots.txt.
- study: 0.3%Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
- study: 5.5%DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
- study: 1.9%Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
- study: 25.1%llms.txtNot met
Publish an llms.txt with a short summary and the key links.
- study: 93.4%AI bot rulesPartly met
Add explicit robots.txt groups for the main AI crawlers.
- study: 1.4%Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
- study: 0.2%Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
- study: 0.3%API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
- study: 11.8%OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
- study: 10.3%OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
- study: 0.0%auth.mdNot met
Publish an auth.md describing how agents sign in.
- study: 0.2%MCP Server CardNot met
Offer an MCP server and publish its server card under /.well-known.
- study: 0.1%A2A Agent CardNot met
Publish an agent card at /.well-known/agent-card.json.
- study: 0.2%Agent SkillsNot met
Publish a skills index with the main tasks agents can do.
- study: 33.7%WebMCPCould not check
Register key actions such as search or cart as WebMCP tools.
- study: 0.1%ARD manifestNot met
Publish an ai-catalog.json listing every agent interface.
Score 24 of 100 · 97% of checks could run · checked on October 5, 2026 · halozyme.com · 2,047 companies scanned
4 of 14 passed. This list is for your technical team. The percentage is how many companies in the study pass each check.
These 14 checks ran during the audit and are what the AI readiness part of the overall score counts. The scan above ran later and is stricter on Link headers and Markdown, so a check can pass here and not there.
Show the 14 checksHide them
- Passedrobots.txt publishedstudy: 85.0%
- PassedXML sitemapstudy: 73.2%
- PassedHTTP Link headers (RFC 8288)study: 29.0%
- Not metMarkdown content negotiationstudy: 8.3%
- Not metllms.txt publishedstudy: 21.7%
- PassedToken budget (page weight)study: 95.2%
- Not metExplicit AI bot rulesstudy: 13.0%
- Not metAPI Catalog (.well-known/api-catalog)study: 0.2%
- Not metOAuth Authorization Server discoverystudy: 10.1%
- Not metOAuth Protected Resource discoverystudy: 9.3%
- Not metMCP Server Cardstudy: 0.0%
- Not metA2A Agent Cardstudy: 0.0%
- Not metWebMCP toolsstudy: 4.2%
- Not metAgent Skills declaredstudy: 0.0%
This website sets no rules for any AI crawler by name, like 84% of the websites whose rules we could read. Every AI crawler follows its general rules.
- GPTBotpartly
- ClaudeBotpartly
- Anthropic-AIpartly
- Google-Extendedpartly
- Applebot-Extendedpartly
- Meta-ExternalAgentpartly
- FacebookBotpartly
- Bytespiderpartly
- CCBotpartly
- Diffbotpartly
- Omgilibotpartly
- OAI-SearchBotpartly
- Claude-SearchBotpartly
- PerplexityBotpartly
- Applebotpartly
- Amazonbotpartly
- YouBotpartly
- ChatGPT-Userpartly
- Claude-Userpartly
- Perplexity-Userpartly
- DuckAssistBotpartly
- MistralAI-Userpartly
Read from the website’s own rules file (robots.txt). An asterisk marks a crawler the file names. The rest follow its general rules. “Partly” means only some pages are blocked.
How many times each website was listed as a source in these answers
In the study as US-listed.
- What are the leading options besides proprietary drug delivery enhancers for increasing bioavailability?
- How do development and licensing fees for innovative drug delivery platforms usually compare?
- Which drug delivery technologies are most suitable for at-home administration by patients?
- Is investing in next-generation drug delivery platforms worth it for hospital outpatient therapies?
- What is the typical cost range for advanced drug delivery technologies in the US healthcare market?
- Alternatives to enzymatic drug delivery solutions for enhanced subcutaneous administration
- Key differences between subcutaneous and intravenous drug delivery methods
- Best drug delivery solutions for improving patient experience in chronic disease management
- How to troubleshoot inconsistent absorption rates in innovative drug delivery devices?
- Common issues encountered when implementing new drug delivery systems in a hospital setting
- Emerging trends in drug delivery technology for pharmaceutical partnerships in the United States
- Are advanced drug delivery devices cost-effective for clinical trial applications?
- What are the most innovative drug delivery technologies currently used to enhance patient experience in the US?
- How do needle-free injectors compare to traditional injection devices for drug delivery?
- Best advanced drug delivery systems for pharmaceutical companies targeting self-administered treatments
Columns, left to right: OpenAI, Claude, Perplexity, Gemini. The AI assistants often disagree. Across the study, on 40% of the questions where a company is named, only one of the four names it.